Nutex Health Inc.: Form 10-Q for the period ended Sep 30, 2017
Filed with the SEC on Nov 20, 2017 and accepted by EDGAR at Nov 20, 2017, 14:22 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cost of revenue | 3 months2017-07-01 to 2017-09-30 | $8.0k | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2017-01-01 to 2017-09-30 | $22.6k | us-gaap:CostOfRevenue |
| Gross profit | 3 months2017-07-01 to 2017-09-30 | $11.1k | us-gaap:GrossProfit |
| Gross profit | 9 months2017-01-01 to 2017-09-30 | $5.4k | us-gaap:GrossProfit |
| Operating income | 3 months2017-07-01 to 2017-09-30 | −$711.9k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2017-01-01 to 2017-09-30 | −$2.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2017-07-01 to 2017-09-30 | $16.7k | us-gaap:InterestExpense |
| Interest expense | 9 months2017-01-01 to 2017-09-30 | $30.3k | us-gaap:InterestExpense |
| Net income | 3 months2017-07-01 to 2017-09-30 | $6.3m | us-gaap:NetIncomeLoss |
| Net income | 9 months2017-01-01 to 2017-09-30 | $4.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2017-07-01 to 2017-09-30 | $0.06 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months2017-01-01 to 2017-09-30 | $0.06 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months2017-01-01 to 2017-09-30 | −$523.5k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2017-09-30 | $15.5k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-09-30 | $87.7k | us-gaap:AssetsCurrent |
| Total assets | At period end2017-09-30 | $6.6m | us-gaap:Assets |
| Total liabilities | At period end2017-09-30 | $734.0k | us-gaap:Liabilities |
| Shareholders' equity | At period end2017-09-30 | $5.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001607062-17-000400. Last ingested by Listed: Nov 14, 2026, 12:46 ET. Listed shows no prices and gives no investment advice.